Filing Details
- Accession Number:
- 0001140361-18-003133
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-24 20:22:18
- Reporting Period:
- 2018-01-22
- Accepted Time:
- 2018-01-24 20:22:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1367644 | Emergent Biosolutions Inc. | EBS | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1294935 | M Jerome Hauer | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-01-22 | 5,152 | $25.47 | 23,797 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-01-22 | 5,152 | $50.91 | 18,645 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-23 | 2,577 | $50.25 | 16,068 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2018-01-22 | 5,152 | $0.00 | 5,152 | $25.47 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2022-01-21 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Hauer.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.25 to $51.25, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- Consists of an option granted on January 22, 2015 under the company's stock incentive plan as amended and restated.
- The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.